Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition

Overexpression of MYC is a genuine cancer driver in lymphomas and related to poor prognosis. However, therapeutic targeting of the transcription factor MYC remains challenging. Here, we show that inhibition of the histone deacetylase 6 (HDAC6) using the HDAC6 inhibitor Marbostat-100 (M-100) reduces...

ver descrição completa

Detalhes bibliográficos
Autores: Winkler, René|||0000-0002-7570-0242, Mägdefrau, A.S.|||0000-0001-6421-2422, Piskor, E.M.|||0000-0003-2109-4627, Kleemann, M.|||0000-0001-6722-7646, Beyer, M., Linke, K.|||0000-0001-6849-2994, Hansen, L., Schaffer, A.M.|||0000-0002-2561-0820, Hoffmann, M.E.|||0000-0002-5381-3043, Poepsel, S., Heyd, F., Beli, P.|||0000-0001-9507-9820, Möröy, T., Mahboobi, S., Krämer, O.H.|||0000-0003-3973-045X, Kosan, C.|||0000-0002-8387-3653
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Universitat Autònoma de Barcelona
Repositório:Dipòsit Digital de Documents de la UAB
Idioma:inglês
OAI Identifier:oai:ddd.uab.cat:270619
Acesso em linha:https://ddd.uab.cat/record/270619
https://dx.doi.org/urn:doi:10.1038/s41388-022-02450-3
Access Level:Acceso aberto
Palavra-chave:Acetylation
Animals
Heat-Shock Proteins
Histone Deacetylase 6
Histone Deacetylase Inhibitors
Histone Deacetylases
HSP40 Heat-Shock Proteins
Humans
Lymphoma, B-Cell
Mice
Transcription Factors
Tubulin
Descrição
Resumo:Overexpression of MYC is a genuine cancer driver in lymphomas and related to poor prognosis. However, therapeutic targeting of the transcription factor MYC remains challenging. Here, we show that inhibition of the histone deacetylase 6 (HDAC6) using the HDAC6 inhibitor Marbostat-100 (M-100) reduces oncogenic MYC levels and prevents lymphomagenesis in a mouse model of MYC-induced aggressive B-cell lymphoma. M-100 specifically alters protein-protein interactions by switching the acetylation state of HDAC6 substrates, such as tubulin. Tubulin facilitates nuclear import of MYC, and MYC-dependent B-cell lymphoma cells rely on continuous import of MYC due to its high turn-over. Acetylation of tubulin impairs this mechanism and enables proteasomal degradation of MYC. M-100 targets almost exclusively B-cell lymphoma cells with high levels of MYC whereas non-tumor cells are not affected. M-100 induces massive apoptosis in human and murine MYC-overexpressing B-cell lymphoma cells. We identified the heat-shock protein DNAJA3 as an interactor of tubulin in an acetylation-dependent manner and overexpression of DNAJA3 resulted in a pronounced degradation of MYC. We propose a mechanism by which DNAJA3 associates with hyperacetylated tubulin in the cytoplasm to control MYC turnover. Taken together, our data demonstrate a beneficial role of HDAC6 inhibition in MYC-dependent B-cell lymphoma.